Skip to main content

Stefan Huemmer

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Stefan Huemmer

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Patologia molecular translacional

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Teresa Moline Marimon, Jessica Camacho Soriano, Carmela Iglesias i Felip, Josep Castellví Vives, Elena Muro Blanc, Marta Cano Galietero, Elena Antima Martinez Saez, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Trond Aasen, Stefan Hummer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 01138
Duration: 01/01/2022 - 30/06/2025

Targeting extracelluar vesicel mediated intercellular communication as a novel approach to combat cancer metastasis.

IP: Stefan Hummer
Collaborators: Santiago Ramon y Cajal Agüeras, Elena Muro Blanc, Vicente Peg Camara, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras, Santiago Ramon y Cajal Agüeras
Funding agency: Fundación Ramón Areces
Funding: 127486
Reference: CIVP21S13325
Duration: 06/07/2023 - 05/07/2026

Protuberancias intercelulares reguladas por Cx43 en cáncer: elucidación funcional, descubrimiento de objetivos, desarrollo de biomarcadores y detección de tumores

IP: Trond Aasen
Collaborators: Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Teresa Moline Marimon, Marta Sese Faustino, Irene Sansano Valero, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI21/00470
Duration: 01/01/2022 - 30/06/2026

Targeting the MNK/eIF4E axis in cancer: a rational approach to enhance tumor sensitivity to chemo- and immunotherapy.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Marta Sese Faustino, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI20/01687
Duration: 01/01/2021 - 31/12/2023

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Related professionals

Imane EL Haddioui Assarraj

Imane EL Haddioui Assarraj

Maintenance staff and general services
Infectious Diseases
Read more
Laura Garriga Grimau

Laura Garriga Grimau

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Maria Eugenia Palacio Lacambra

Maria Eugenia Palacio Lacambra

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Arantxa Ibarz Casas

Arantxa Ibarz Casas

Research technician
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.